Beijing, Jun 15: China is locking now ten more neighbourhoods in Beijing to try and contain the spread of a new coronavirus outbreak linked to a food market, authorities announced Monday.
City official Li Junjie said at a press conference that fresh cases had been found in a second wholesale market in northwestern Haidian district, and as a result, the market and nearby schools would be closed, and people living in ten communities around it placed under lockdown.
Hubei, Feb 10: The death toll in the deadly coronavirus outbreak in China and other parts of the world has reached 904, CNN reported citing Chinese authorities on Monday.
The number of infected people globally has now hit the 40,000 mark.
According to the country's health officials, the number of people, who died from coronavirus in the Hubei Province, has risen to 871.
"As of 24:00 on February 9, Hubei Province reported a total of 29,631 cases of new coronavirus pneumonia, including 16,902 cases in Wuhan. 22,160 patients are still being treated in hospitals. 73,127 people remain under medical observation," read the statement from the Chinese Regional Health Committee.
The novel coronavirus was first detected in China's Wuhan city in late December and has since spread to more than 25 countries.
On Sunday, the new coronavirus even surpassed the fatalities caused by the SARS epidemic in 2003.
The World Health Organisation (WHO) has declared a global health emergency in the wake of the outbreak.
Meanwhile, WHO's international expert mission led by Dr Bruce Aylward embarked for China.
Geneva, Jul 2: The World Health Organization (WHO) has estimated the overall number of coronavirus cases globally at 10,357,662, with 508,055 people having died from the disease.
The UN health agency said in the situation report published on late Wednesday that 163,939 new cases had been recorded in the past day, while further 4,188 patients had died.
Americas continue to lead the count with over 5.2 million cases, followed by Europe with more than 2.7 million.
The WHO declared the COVID-19 outbreak a pandemic on March 11.
Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.
The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.
Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.
"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.
Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.
Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.
Comments
Add new comment